326 related articles for article (PubMed ID: 14662257)
1. Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure?
Khand AU; Rankin AC; Martin W; Taylor J; Gemmell I; Cleland JG
J Am Coll Cardiol; 2003 Dec; 42(11):1944-51. PubMed ID: 14662257
[TBL] [Abstract][Full Text] [Related]
2. The effect of carvedilol on B-type natriuretic peptide and cardiac function in patients with heart failure and persistent atrial fibrillation.
Khand AU; Chew PG; Douglas H; Jones J; Jan A; Cleland JG
Cardiology; 2015; 130(3):153-8. PubMed ID: 25660493
[TBL] [Abstract][Full Text] [Related]
3. Comparison of beta blocker and digoxin alone and in combination for management of patients with atrial fibrillation and heart failure.
Fauchier L; Grimard C; Pierre B; Nonin E; Gorin L; Rauzy B; Cosnay P; Babuty D; Charbonnier B
Am J Cardiol; 2009 Jan; 103(2):248-54. PubMed ID: 19121446
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of efficacy and safety of low-dose diltiazem or betaxolol in combination with digoxin to control ventricular rate in chronic atrial fibrillation: randomized crossover study.
Koh KK; Song JH; Kwon KS; Park HB; Baik SH; Park YS; In HH; Moon TH; Park GS; Cho SK
Int J Cardiol; 1995 Nov; 52(2):167-74. PubMed ID: 8749878
[TBL] [Abstract][Full Text] [Related]
5. Role of carvedilol in atrial fibrillation: insights from clinical trials.
Gheorghiade M; Lukas MA
Am J Cardiol; 2004 May; 93(9A):53B-7B. PubMed ID: 15144939
[TBL] [Abstract][Full Text] [Related]
6. Impact of digoxin on risk of death in heart failure patients treated with b-blockers. Results from Polish part of ESC Heart Failure Long-Term Registry.
Migaj J; Kałużna-Oleksy M; Nessler J; Opolski G; Crespo-Leiro MG; Maggioni AP; Grajek S; Ponikowski P; Drożdż J; Straburzyńska-Migaj E
Kardiol Pol; 2018; 76(7):1064-1072. PubMed ID: 29476617
[TBL] [Abstract][Full Text] [Related]
7. Heart rate control by carvedilol in Japanese patients with chronic atrial fibrillation: The AF Carvedilol study.
Inoue H; Atarashi H; Okumura K; Yamashita T; Fukuzawa M; Shiosakai K; Kimura T
J Cardiol; 2017 Jan; 69(1):293-301. PubMed ID: 27364549
[TBL] [Abstract][Full Text] [Related]
8. Antiadrenergic therapy in the control of atrial fibrillation.
Naccarelli GV
J Cardiovasc Pharmacol Ther; 2005 Jun; 10 Suppl 1():S33-43. PubMed ID: 15965571
[TBL] [Abstract][Full Text] [Related]
9. Aspirin impairs reverse myocardial remodeling in patients with heart failure treated with beta-blockers.
Lindenfeld J; Robertson AD; Lowes BD; Bristow MR;
J Am Coll Cardiol; 2001 Dec; 38(7):1950-6. PubMed ID: 11738299
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy with carvedilol and amiodarone in patients with severe heart failure.
Nägele H; Bohlmann M; Eck U; Petersen B; Rödiger W
Eur J Heart Fail; 2000 Mar; 2(1):71-9. PubMed ID: 10742706
[TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blind comparison of intravenous diltiazem and digoxin for atrial fibrillation after coronary artery bypass surgery.
Tisdale JE; Padhi ID; Goldberg AD; Silverman NA; Webb CR; Higgins RS; Paone G; Frank DM; Borzak S
Am Heart J; 1998 May; 135(5 Pt 1):739-47. PubMed ID: 9588402
[TBL] [Abstract][Full Text] [Related]
12. A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II Study).
Shelton RJ; Clark AL; Goode K; Rigby AS; Houghton T; Kaye GC; Cleland JG
Heart; 2009 Jun; 95(11):924-30. PubMed ID: 19282313
[TBL] [Abstract][Full Text] [Related]
13. Is beta-blockade useful in heart failure patients with atrial fibrillation? An analysis of data from two previously completed prospective trials.
Fung JW; Chan SK; Yeung LY; Sanderson JE
Eur J Heart Fail; 2002 Aug; 4(4):489-94. PubMed ID: 12167389
[TBL] [Abstract][Full Text] [Related]
14. Comparison of four single-drug regimens on ventricular rate and arrhythmia-related symptoms in patients with permanent atrial fibrillation.
Ulimoen SR; Enger S; Carlson J; Platonov PG; Pripp AH; Abdelnoor M; Arnesen H; Gjesdal K; Tveit A
Am J Cardiol; 2013 Jan; 111(2):225-30. PubMed ID: 23111138
[TBL] [Abstract][Full Text] [Related]
15. Relation of digoxin use in atrial fibrillation and the risk of all-cause mortality in patients ≥65 years of age with versus without heart failure.
Shah M; Avgil Tsadok M; Jackevicius CA; Essebag V; Behlouli H; Pilote L
Am J Cardiol; 2014 Aug; 114(3):401-6. PubMed ID: 24950677
[TBL] [Abstract][Full Text] [Related]
16. Digoxin Use and Subsequent Clinical Outcomes in Patients With Atrial Fibrillation With or Without Heart Failure in the ENGAGE AF-TIMI 48 Trial.
Eisen A; Ruff CT; Braunwald E; Hamershock RA; Lewis BS; Hassager C; Chao TF; Le Heuzey JY; Mercuri M; Rutman H; Antman EM; Giugliano RP
J Am Heart Assoc; 2017 Jun; 6(7):. PubMed ID: 28666993
[TBL] [Abstract][Full Text] [Related]
17. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: approaches to control rate in atrial fibrillation.
Olshansky B; Rosenfeld LE; Warner AL; Solomon AJ; O'Neill G; Sharma A; Platia E; Feld GK; Akiyama T; Brodsky MA; Greene HL;
J Am Coll Cardiol; 2004 Apr; 43(7):1201-8. PubMed ID: 15063430
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of labetalol in chronic atrial fibrillation.
Wong CK; Lau CP; Leung WH; Cheng CH
Am J Cardiol; 1990 Nov; 66(17):1212-5. PubMed ID: 2239725
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic management of atrial fibrillation: current therapeutic strategies.
Lévy S
Am Heart J; 2001 Feb; 141(2 Suppl):S15-21. PubMed ID: 11174354
[TBL] [Abstract][Full Text] [Related]
20. A review of rate control in atrial fibrillation, and the rationale and protocol for the RATE-AF trial.
Kotecha D; Calvert M; Deeks JJ; Griffith M; Kirchhof P; Lip GY; Mehta S; Slinn G; Stanbury M; Steeds RP; Townend JN
BMJ Open; 2017 Jul; 7(7):e015099. PubMed ID: 28729311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
